SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Array Biopharma, Inc
An SI Board Since March 2005
Posts SubjectMarks Bans Symbol
321 29 0 ARRY
Emcee:  keokalani'nui Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
296>> Seems to me that Novartis, if forced to return MEK162 to Array, is a tascaram(o)uche-6/2/2014
295>> aside, regarding loxo-101 << One for 1 in trkA-positive. Large scaram(o)uche-5/31/2014
294>> Seems to me that Novartis, if forced to return MEK162 to Array, is a tascaram(o)uche-5/30/2014
293LEE011/MEK162 combo data presentation is on Sunday. Two trading days left. Lonscaram(o)uche-5/28/2014
2922014 Europ. Hematol. Assn. ARRY-520 abstract out... Abstract P370: A PHASE 1 STscaram(o)uche-5/21/2014
291Pfizer or no Pfizer, AZN still launching new trials with selumetinib. Link (comscaram(o)uche-5/21/2014
290>> (tgtx) recovered today for a solid 10% plus from where I entered. I'scaram(o)uche-5/21/2014
289>> Squarer sounded anxious in the last conference call, but he must actualscaram(o)uche-5/20/2014
288We've been discussing: 1. the taflinar/mekinist (dabrafinib/trametinib) coscaram(o)uche-5/18/2014
287>> Tough small cap sledding << My other small cap abstract-release scaram(o)uche-5/15/2014
286Thanks, Nigel. If you haven't listened to the BofA-ML presentation, there wscaram(o)uche-5/15/2014
285<i>Thoughts?</i> Given the history of pharma decision making, and lnigel bates-5/15/2014
284OK, I have a question. Anybody know anything about antitrust in this situation?scaram(o)uche-5/15/2014
283Geeeeze, today was a TOUGH day to trade ASCO14. :-( >> My opinion (I'scaram(o)uche-5/13/2014
282>> platform << Boiler plate wording for follow-on offerings?? ;-)scaram(o)uche-4/22/2014
281GILD has $2.3bn in Sovaldi sales for the first quarter. More than twice $1bn conBrian Sullivan-4/22/2014
280I'm hoping that a few traders got short today, heading to ASCO. Just noticescaram(o)uche-4/22/2014
279Welcome aboard Rick. I have been holding a couple slugs since late '12 to wmopgcw-4/22/2014
278Fascinating day yesterday for ARRY. All mek balls are in the air! There was thscaram(o)uche-4/22/2014
277My view, one of the coolest human experiments ever conceived..... >> Safescaram(o)uche-12/3/2013
276fwiw, since I'm on the page..... ash.confex.comscaram(o)uche-11/7/2013
275Thanks. Lost touch. Best!scaram(o)uche-10/22/2013
274Yep, NVS is already running a MEK162+LEE011 combo trial in NRAS melanoma: clinicmcbio-10/21/2013
273>> tweeting for ASH << AACR-NCI-EORTC, sorry.scaram(o)uche-10/21/2013
272>> Next, we might watch for a telegraphed combo, 162 and LEE011 (CDK4/6 inscaram(o)uche-10/21/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News